Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar 18:5:10.
doi: 10.1186/1756-8722-5-10.

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

Meng Lv  1 , Xiao-Jun Huang
Affiliations
Review

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go

Meng Lv et al. J Hematol Oncol. .

Abstract

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective and sometimes the only curative therapy for patients with certain hematological diseases. Allo-HSCT has been practiced in China for approximately 30 years, and great improvements have been made within the past decade, particularly in fields such as the haploidentical HSCT system, strategies to overcome relapse and GVHD, and modified HSCT for elderly patients. This review will describe the current situation and provide a prospective of these unique aspects of Allo-HSCT in China.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The types of donor sources for allo-HSCT in China.
Figure 2
Figure 2
The distribution of diseases of allo-HSCT recipients in China.
See this image and copyright information in PMC

References

    1. Lu DP, Guo NL, Jin NR, Zheng H, Lu XJ, Shi Q, Shan FX, Jiang B, Tang H, Liu MY. Allogeneic bone marrow transplantation for the treatment of leukemia. Chin Med J (Engl) 1990;103:125–130. - PubMed
    1. Xu LP, Huang XJ. Current status and development of hematopoietic stem cell transplantation in China: a report from Chinese Hematopoietic Stem Cell Transplantation Register Group. Chin Med J (Engl) 2011;124:2548–2555. - PubMed
    1. Pasquini MCWZ. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2011. http://www.cibmtr.org
    1. Jiang Q, Xu LP, Liu DH, Liu KY, Chen SS, Jiang B, Jiang H, Chen H, Chen YH, Han W. et al.Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. Blood. 2011;117:3032–3040. doi: 10.1182/blood-2010-09-308510. - DOI - PubMed
    1. Huang XJ. Current status of haploidentical stem cell transplantation for leukemia. J Hematol Oncol. 2008;1:27. doi: 10.1186/1756-8722-1-27. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources